Katsuyama, Eri
Miyawaki, Yoshia
Sada, Ken-ei http://orcid.org/0000-0003-1020-0818
Asano, Yosuke
Hayashi, Keigo
Yamamura, Yuriko
Hiramatsu-Asano, Sumie
Morishita, Michiko
Ohashi, Keiji
Watanabe, Haruki
Katsuyama, Takayuki
Narazaki, Mariko
Matsumoto, Yoshinori
Wada, Jun
Article History
Received: 13 December 2019
Accepted: 25 May 2020
First Online: 1 June 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committees of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences (authorization number: Ken 1905–017), and conducted according to the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. Patient consent was obtained using an opt-out approach.
: Not applicable.
: JW has received speaking honoraria from Astellas, Boehringer Ingelheim, Daiichi Novartis, Sankyo, and Tanabe Mitsubishi, as well as grant support from Astellas, Bayer, Baxter, Chugai, Daiichi Sankyo, Kissei, Kyowa Hakko Kirin, MSD, Novartis, Novo Nordisk, Ono, Otsuka, Pfizer, Teijin, Torii, and Takeda. All other authors declare that they have no competing interests.